Elanco Animal Health (ELAN) Revenue & Revenue Breakdown
Elanco Animal Health Revenue Highlights
Latest Revenue (Y)
$4.71B
Latest Revenue (Q)
$1.14B
Main Segment (Y)
Farm Animal
Main Geography (Y)
Non-US
Elanco Animal Health Revenue by Period
Elanco Animal Health Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2025-12-31 | $4.71B | 6.22% |
| 2024-12-31 | $4.44B | 0.50% |
| 2023-12-31 | $4.42B | 0.14% |
| 2022-12-31 | $4.41B | -7.41% |
| 2021-12-31 | $4.76B | 45.54% |
| 2020-12-31 | $3.27B | 6.59% |
| 2019-12-31 | $3.07B | 0.14% |
| 2018-12-31 | $3.07B | 6.15% |
| 2017-12-31 | $2.89B | -0.84% |
| 2016-12-31 | $2.91B | 0.15% |
| 2015-12-31 | $2.91B | - |
Elanco Animal Health generated $4.71B in revenue during NA 2025, up 6.22% compared to the previous quarter, and up 144.04% compared to the same period a year ago.
Elanco Animal Health Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-09-30 | $1.14B | -8.38% |
| 2025-06-30 | $1.24B | 4.02% |
| 2025-03-31 | $1.19B | 16.96% |
| 2024-12-31 | $1.02B | -0.97% |
| 2024-09-30 | $1.03B | -13.01% |
| 2024-06-30 | $1.18B | -1.74% |
| 2024-03-31 | $1.21B | 16.43% |
| 2023-12-31 | $1.03B | -3.09% |
| 2023-09-30 | $1.07B | 1.04% |
| 2023-06-30 | $1.06B | -15.91% |
| 2023-03-31 | $1.26B | 27.23% |
| 2022-12-31 | $988.00M | -3.70% |
| 2022-09-30 | $1.03B | -12.68% |
| 2022-06-30 | $1.18B | -4.16% |
| 2022-03-31 | $1.23B | 10.15% |
| 2021-12-31 | $1.11B | -1.59% |
| 2021-09-30 | $1.13B | -11.57% |
| 2021-06-30 | $1.28B | 2.98% |
| 2021-03-31 | $1.24B | 8.98% |
| 2020-12-31 | $1.14B | 28.11% |
| 2020-09-30 | $889.60M | 51.73% |
| 2020-06-30 | $586.30M | -10.86% |
| 2020-03-31 | $657.70M | -16.43% |
| 2019-12-31 | $787.00M | 2.04% |
| 2019-09-30 | $771.30M | -1.32% |
| 2019-06-30 | $781.60M | 6.91% |
| 2019-03-31 | $731.10M | -8.53% |
| 2018-12-31 | $799.30M | 5.02% |
| 2018-09-30 | $761.10M | -1.18% |
| 2018-06-30 | $770.20M | 4.62% |
| 2018-03-31 | $736.20M | -2.40% |
| 2017-12-31 | $754.30M | 8.21% |
| 2017-09-30 | $697.10M | -3.02% |
| 2017-06-30 | $718.80M | - |
| 2017-03-31 | $718.80M | - |
Elanco Animal Health generated $1.14B in revenue during Q3 2025, up -8.38% compared to the previous quarter, and up 96.03% compared to the same period a year ago.
Elanco Animal Health Revenue Breakdown
Elanco Animal Health Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 25 | Dec 24 | Dec 22 | Dec 21 | Dec 20 |
|---|---|---|---|---|---|
| Farm Animal | $2.36B | $2.25B | $2.22B | $2.33B | - |
| Swine | $379.00M | $366.00M | $384.00M | - | - |
| Pet Health | $2.30B | $2.14B | $2.14B | $2.35B | - |
| Contract Manufacturing | $53.00M | $46.00M | $54.00M | $82.00M | $80.20M |
| Cattle | $1.13B | $1.01B | $944.00M | - | - |
| Poultry | $858.00M | $796.00M | $716.00M | - | - |
| Farm Animal Future Protein And Health | - | - | - | - | $734.10M |
| Pet Health Disease Prevention | - | - | - | - | $992.70M |
| Farm Animal Ruminants And Swine | - | - | - | - | $1.10B |
| Pet Health Therapeutics | - | - | - | - | $365.80M |
Elanco Animal Health's latest annual revenue breakdown by segment (product or service), as of Dec 25: Farm Animal (33.38%), Pet Health (32.50%), Cattle (15.90%), Poultry (12.12%), Swine (5.36%), and Contract Manufacturing (0.75%).
Quarterly Revenue by Product
| Product/Service | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Mar 24 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Farm Animal | $640.00M | $593.00M | $583.00M | $546.00M | $1.16B | $530.00M | $556.00M | $561.00M | $527.00M | $573.00M | $552.00M | $545.00M | $553.00M | $569.00M | $604.00M | $583.00M | $567.00M | $578.00M | - | - |
| Contract Manufacturing | $15.00M | $11.00M | $15.00M | $12.00M | $22.00M | $14.00M | $10.00M | $12.00M | $12.00M | $9.00M | $13.00M | $12.00M | $12.00M | $17.00M | $15.00M | $21.00M | $27.00M | $19.00M | $29.20M | $16.10M |
| Cattle | $296.00M | $289.00M | $268.00M | $272.00M | $510.00M | $253.00M | $244.00M | $242.00M | $210.00M | $248.00M | $222.00M | $227.00M | $248.00M | - | - | - | - | - | - | - |
| Swine | $107.00M | $87.00M | $100.00M | $85.00M | $194.00M | $88.00M | $84.00M | $93.00M | $89.00M | $102.00M | $100.00M | $95.00M | $89.00M | - | - | - | - | - | - | - |
| Poultry | $237.00M | $217.00M | $215.00M | $189.00M | $411.00M | $188.00M | $197.00M | $184.00M | $178.00M | $183.00M | $187.00M | $176.00M | $174.00M | - | - | - | - | - | - | - |
| Pet Health | $489.00M | $533.00M | $643.00M | $635.00M | $1.02B | $486.00M | $639.00M | $495.00M | $518.00M | $675.00M | $416.00M | $471.00M | $612.00M | $639.00M | $494.00M | $527.00M | $685.00M | $645.00M | - | - |
| Pet Health Therapeutics | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $118.70M | $103.30M |
| Pet Health Disease Prevention | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $379.10M | $297.00M |
| Farm Animal Ruminants And Swine | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $397.40M | $292.30M |
| Farm Animal Future Protein And Health | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $215.30M | $180.90M |
Elanco Animal Health's latest quarterly revenue breakdown by segment (product or service), as of Dec 25: Farm Animal (35.87%), Pet Health (27.41%), Cattle (16.59%), Poultry (13.28%), Swine (6.00%), and Contract Manufacturing (0.84%).
Elanco Animal Health Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 25 | Dec 24 | Dec 22 | Dec 21 | Dec 20 |
|---|---|---|---|---|---|
| Non-US | $2.48B | $2.40B | $2.45B | $2.64B | $1.80B |
| UNITED STATES | $2.23B | $2.04B | $1.97B | $2.12B | $1.48B |
Elanco Animal Health's latest annual revenue breakdown by geography, as of Dec 25: Non-US (52.62%), and UNITED STATES (47.38%).
Quarterly Revenue by Country
| Country | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Mar 24 | Sep 23 | Jun 23 | Mar 23 | Sep 22 | Jun 22 | Mar 22 | Sep 21 | Jun 21 | Mar 21 | Sep 20 | Jun 20 | Mar 20 | Sep 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| UNITED STATES | $540.00M | $547.00M | $593.00M | $554.00M | $1.02B | $487.00M | $531.00M | $479.00M | $500.00M | $543.00M | $475.00M | $539.00M | $522.00M | $507.00M | $581.00M | $533.00M | $421.50M | $248.10M | $299.90M | $388.20M |
| Non-US | $604.00M | $590.00M | $648.00M | $639.00M | $1.19B | $543.00M | $674.00M | $589.00M | $557.00M | $714.00M | $553.00M | $638.00M | $703.00M | $624.00M | $698.00M | $709.00M | $468.10M | $338.20M | $357.80M | $383.10M |
Elanco Animal Health's latest quarterly revenue breakdown by geography, as of Dec 25: Non-US (52.80%), and UNITED STATES (47.20%).
Elanco Animal Health Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| RDY | Dr. Reddy's Laboratories | $279.16B | - |
| VTRS | Viatris | $14.30B | $3.76B |
| SOLV | Solventum | $8.32B | $2.10B |
| EHC | Encompass Health | $5.94B | $1.48B |
| ENSG | Ensign Group | $5.06B | $1.30B |
| ELAN | Elanco Animal Health | $4.71B | $1.14B |
| ALGN | Align | $4.03B | $995.69M |
| NBIX | Neurocrine Biosciences | $2.86B | $794.90M |
| RVTY | Revvity | $2.86B | $698.95M |
| QGEN | Qiagen | $1.97B | $458.80M |
| RVMD | Revolution Medicines | - | - |